Refresh

Jubilant Pharmova Ltd. - Research Center

530019 JUBLPHARMA Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

810.12 87.75 2,709.50 3,139.90 3,438.61
Expenses

Material consumed

414.55 - 1,564.02 1,820.77 2,185.94

Manufacturing expenses

75.37 9.27 280.40 369.20 358.28

Personnel expenses

167.27 49.21 220.67 264.90 265.71

Selling expenses

1.43 0.33 0.26 4.20 4.53

Adminstrative expenses

148.26 35.72 217.08 309.93 303.28

Expenses capitalised

- - - - -

Cost of sales

806.89 94.54 2,282.44 2,769.00 3,117.74

Operating profit

3.23 -6.79 427.06 370.90 320.88

Other recurring income

137.89 125.87 47.88 173.23 78.00

Adjusted PBDIT

141.12 119.08 474.94 544.14 398.88

Financial expenses

18.52 30.59 101.80 136.20 128.96

Depreciation

43.25 6.25 99.97 107.40 86.48

Other write offs

- - - - -

Adjusted PBT

79.34 82.25 273.17 300.54 183.43

Tax charges

29.46 3.75 58.69 -22.30 35.80

Adjusted PAT

49.88 78.50 214.48 322.84 147.63

Non recurring items

-0.77 0.25 -0.71 -3.67 -1.11

Other non cash adjustments

- - - - -

Reported net profit

49.11 78.75 213.77 319.18 146.52

Earnigs before appropriation

1,203.14 1,233.67 1,367.03 1,306.10 1,098.22

Equity dividend

79.64 79.64 - 149.80 39.44

Preference dividend

- - - - -

Dividend tax

- - - 1.52 8.35

Retained earnings

1,123.50 1,154.03 1,367.03 1,154.78 1,050.44
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com